A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models

Title
A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models
Authors
Keywords
Autoimmune, Coxsackievirus, Enterovirus, Neutralising antibodies, Non-obese diabetic mouse, Type 1 diabetes, Vaccine
Journal
DIABETOLOGIA
Volume 58, Issue 2, Pages 346-354
Publisher
Springer Nature
Online
2014-11-05
DOI
10.1007/s00125-014-3436-0

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started